TY - JOUR
T1 - Variable protease-sensitive prionopathy transmission to bank voles
AU - Nonno, Romolo
AU - Notari, Silvio
AU - Di Bari, Michele Angelo
AU - Cali, Ignazio
AU - Pirisinu, Laura
AU - D’agostino, Claudia
AU - Cracco, Laura
AU - Kofskey, Diane
AU - Vanni, Ilaria
AU - Lavrich, Jody
AU - Parchi, Piero
AU - Agrimi, Umberto
AU - Gambetti, Pierluigi
N1 - Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Università di Bologna Parchi Piero).
Richiesto "CORRIGENDUM" per modifica di affiliazione imprecisa.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Variably protease-sensitive prionopathy (VPSPr), a recently described human sporadic prion disease, features a protease-resistant, disease-related prion protein (resPrPD) displaying 5 fragments reminiscent of Gerstmann-Sträussler-Scheinker disease. Experimental VPSPr transmission to human PrP–expressing transgenic mice, although replication of the VPSPr resPrPD profile succeeded, has been incomplete because of second passage failure. We bioassayed VPSPr in bank voles, which are susceptible to human prion strains. Transmission was complete; first-passage attack rates were 5%–35%, and second-passage rates reached 100% and survival times were 50% shorter. We observed 3 distinct phenotypes and resPrPD profiles; 2 imitated sporadic Creutzfeldt-Jakob disease resPrPD, and 1 resembled Gerstmann-Sträussler-Scheinker disease resPrPD. The first 2 phenotypes may be related to the presence of minor PrPD components in VPSPr. Full VPSPr transmission confirms permissiveness of bank voles to human prions and suggests that bank vole PrP may efficiently reveal an under-represented native strain but does not replicate the complex VPSPr PrPD profile.
AB - Variably protease-sensitive prionopathy (VPSPr), a recently described human sporadic prion disease, features a protease-resistant, disease-related prion protein (resPrPD) displaying 5 fragments reminiscent of Gerstmann-Sträussler-Scheinker disease. Experimental VPSPr transmission to human PrP–expressing transgenic mice, although replication of the VPSPr resPrPD profile succeeded, has been incomplete because of second passage failure. We bioassayed VPSPr in bank voles, which are susceptible to human prion strains. Transmission was complete; first-passage attack rates were 5%–35%, and second-passage rates reached 100% and survival times were 50% shorter. We observed 3 distinct phenotypes and resPrPD profiles; 2 imitated sporadic Creutzfeldt-Jakob disease resPrPD, and 1 resembled Gerstmann-Sträussler-Scheinker disease resPrPD. The first 2 phenotypes may be related to the presence of minor PrPD components in VPSPr. Full VPSPr transmission confirms permissiveness of bank voles to human prions and suggests that bank vole PrP may efficiently reveal an under-represented native strain but does not replicate the complex VPSPr PrPD profile.
UR - http://www.scopus.com/inward/record.url?scp=85058772252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058772252&partnerID=8YFLogxK
U2 - 10.3201/eid2501.180807
DO - 10.3201/eid2501.180807
M3 - Article
C2 - 30561322
AN - SCOPUS:85058772252
SN - 1080-6040
VL - 25
SP - 73
EP - 81
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 1
ER -